Format: Presentation
Date:
All company presentations will be available on-demand beginning at
Please find a link to the presentation here.
A webcast of the presentation can also be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com.
About Foghorn Therapeutics
Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology with two currently being investigated in clinical studies.
Contact:
bstrain@foghorntx.com
gregory.kelley@ogilvy.com
hans@lifesciadvisors.com
Source:
2022 GlobeNewswire, Inc., source